Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neoplasma (Bratislava)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15800711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.

  2002cited by this paper
• Influence of p53 mutations on prognosis of patients with glioblastoma

  2002cited by this paper
• Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

  2002cited by this paper
• A ligand for peroxisome proliferator activated receptor γ inhibits cell growth and induces apoptosis in human liver cancer cells

  2002cited by this paper
• Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas.

  2002cited by this paper
• Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes

  2001cited by this paper
• Peroxisome proliferator-activated receptor- gamma expression in human malignant and normal brain, breast and prostate-derived cells.

  2001cited by this paper
• PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture.

  2001cited by this paper
• PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.

  2001cited by this paper
• TP53 Gene Mutations, Nuclear p53 Accumulation, Expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) Proteins are not Prognostic Factors in De Novo Glioblastoma Multiforme

  2001cited by this paper
• Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.

  2001cited by this paper
• Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

  2001cited by this paper
• Carotenoids and retinoids as suppressors on adipocyte differentiation via nuclear receptors.

  2000cited by this paper
• Roles of PPARs in health and disease

  2000cited by this paper
• Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists

  2000cited by this paper
• Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators.

  2000cited by this paper
• Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.

  2000cited by this paper
• Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells.

  2000cited by this paper
• PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer.

  2000cited by this paper
• Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.

  2000cited by this paper
• Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.

  2000cited by this paper
• Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562.

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.

  2000cited by this paper
• The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease.

  2000cited by this paper
• Presence and inducibility of peroxisomes in a human glioblastoma cell line.

  2000cited by this paper
• Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer.

  2000cited by this paper
• PPAR-gamma-mediated regulation of normal and malignant B lineage cells.

  2000cited by this paper
• Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis.

  2000cited by this paper
• Loss-of-function mutations in PPAR gamma associated with human colon cancer.

  1999cited by this paper
• Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

  1999cited by this paper
• Orphan nuclear receptors: shifting endocrinology into reverse.

  1999cited by this paper
• The structure of the nuclear hormone receptors.

  1999cited by this paper
• Terminal differentiation of human breast cancer through PPAR gamma.

  1998cited by this paper
• Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

  1998cited by this paper
• Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system.

  1998cited by this paper
• Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.

  1997cited by this paper
• Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

  1996cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity.

  1987cited by this paper

• Unlocking therapeutic potential: Exploring nuclear receptors in brain cancer treatment

  2025influential citation
• Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet

  2023cites this paper
• The Use of Photodynamic Therapy in the Treatment of Brain Tumors—A Review of the Literature

  2022cites this paper
• Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer

  2022cites this paper
• Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies

  2021cites this paper
• Utilizing systems biology to reveal cellular responses to peroxisome proliferator-activated receptor γ ligand exposure

  2021cites this paper
• The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics.

  2021cites this paper
• Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders

  2021cites this paper
• PPARα plays an important role in the migration activity, and the expression of CYP2S1 and CYP1B1 in chrysin-treated HCT116 cells

  2020cites this paper
• Capsaicin up-regulates pro-apoptotic activity of thiazolidinediones in glioblastoma cell line.

  2020cites this paper
• Do arachidonic acid metabolites affect apoptosis in bovine endometrial cells with silenced PPAR genes?

  2019cites this paper
• Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes

  2018cites this paper
• The effects of fish oil on gene expression in patients with polycystic ovary syndrome

  2018cites this paper
• Circulating exosomal microRNAs reveal the mechanism of Fructus Meliae Toosendan-induced liver injury in mice

  2018cites this paper
• The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome.

  2018cites this paper
• Receptory aktywowane przez proliferatory peroksysomów w procesie nowotworzenia - fakty i kontrowersje

  2018cites this paper
• The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile Polycystic Ovary Syndrome Women Candidate for In Vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial

  2017cites this paper
• Flaxseed Oil Supplementation Improve Gene Expression Levels of PPAR-γ, LP(a), IL-1 and TNF-α in Type 2 Diabetic Patients with Coronary Heart Disease

  2017cites this paper
• Combination Treatment with PPARγ Ligand and Its Specific Inhibitor GW9662 Downregulates BIS and 14-3-3 Gamma, Inhibiting Stem-Like Properties in Glioblastoma Cells

  2017cites this paper
• The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus

  2016cites this paper
• Peroxisome Proliferator‐Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies

  2016cites this paper
• Stimulating effect of normal-dosing of fibrates on cell proliferation: word of warning

  2016cites this paper
• The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome

  2016cites this paper
• Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.

  2015cites this paper
• Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.

  2014cites this paper
• Molecular Mechanisms of Fenofibrate-Induced Metabolic Catastrophe and Glioblastoma Cell Death

  2014cites this paper
• PPARγ1 phosphorylation enhances proliferation and drug resistance in human fibrosarcoma cells.

  2014cites this paper
• The role of aryl hydrocarbon receptor-regulated cytochrome P450 enzymes in glioma.

  2013cites this paper
• Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism.

  2013cites this paper
• In silico Analysis of Transcription Factors Associated to Differentially Expressed Genes in Irradiated Glioblastoma Cell Lines

  2013cites this paper
• Efeitos do Silenciamento de E2F1 e HEB, Fatores de Transcrição Preditos In Silico, em Células de Glioblastoma Irradiadas com Raios Gama.

  2013cites this paper
• Expression of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ) in Human Non-small Cell Lung Carcinoma: Correlation with Clinicopathological Parameters, Proliferation and Apoptosis Related Molecules and Patients’ Survival

  2012cites this paper
• PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis

  2012cites this paper
• Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro

  2012cites this paper
• A systems approach to the different grades and progression of human astrocytoma

  2011cites this paper
• The Anti-tumorigenic Properties of Peroxisomal Proliferator-activated Receptor α Are Arachidonic Acid Epoxygenase-mediated*

  2010cites this paper
• PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors

  2010cites this paper
• Nuclear receptor co-repressor functions in prostate cancer; in vitro, in vivo and in silico approaches

  2010cites this paper
• Peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer

  2010cites this paper
• Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.

  2010cites this paper
• STAT3 as a Therapeutic Target for Glioblastoma.

  2010cites this paper
• Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroids

  2010cites this paper
• Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.

  2009cites this paper
• Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.

  2009cites this paper
• PPARγ and RXRγ ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models

  2009cites this paper
• Cyanide-induced death of dopaminergic cells is mediated by uncoupling protein-2 up-regulation and reduced Bcl-2 expression.

  2009cites this paper
• Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

  2008cites this paper
• ReviewArticle PPARγ and Apoptosis in Cancer

  2008cites this paper
• ReviewArticle PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors

  2008cites this paper
• PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells

  2008cites this paper
• Low-Dose Chemotherapy in Combination with COX-2 Inhibitors and PPAR-Gamma Agonists in Recurrent High-Grade Gliomas – A Phase II Study

  2008cites this paper
• Expression of STATs and their inhibitors SOCS and PIAS in brain tumors. In vitro and in vivo study.

  2008cites this paper
• PPARγ and Apoptosis in Cancer

  2008cites this paper
• PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors

  2008cites this paper
• Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes.

  2007cites this paper
• PPARs in the brain.

  2007cites this paper
• Knocking Out Peroxisome Proliferator-Activated Receptor (PPAR) α Inhibits Radiation-Induced Apoptosis in the Mouse Kidney through Activation of NF-κB and Increased Expression of IAPs

  2007cites this paper
• Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death.

  2007cites this paper
• Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines

  2007cites this paper
• Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts.

  2007cites this paper
• Peroxisome Proliferator-Activated Receptor-- Null Mice Have Increased White Adipose Tissue Glucose Utilization , GLUT 4 , and Fat Mass : Role in Liver and Brain

  2006cites this paper
• The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).

  2006cites this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) Induces Cell Death Through Caspase-independent Mechanism in A172 Human Glioma Cells

  2006cites this paper
• Genoma funcional e análise in silico na caracterização e no isolamento de genes envolvidos em gliomas humanos

  2006influential citation
• Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.

  2006cites this paper
• Molecular mechanisms of insulin resistance in glucagon-producing alpha cells

  2006cites this paper
• PPARalpha-mediated upregulation of uncoupling protein-2 switches cyanide-induced apoptosis to necrosis in primary cortical cells.

  2006cites this paper
• Dual PPARα/γ Ligand TZD18 Either Alone or in Combination with Imatinib Inhibits Proliferation and Induces Apoptosis of Human CML Cell Lines

  2006cites this paper
• Rosiglitazone inhibits endothelial proliferation and angiogenesis.

  2006cites this paper
• Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain.

  2006cites this paper
• 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells.

  2006cites this paper
• Review Article Peroxisome Proliferator-activated Receptors (ppars) as Potential Inducers of Antineoplastic Effects in Cns Tumors

  year unknowncites this paper
• Review Article Peroxisome Proliferator-activated Receptors and Progression of Colorectal Cancer

  year unknowncites this paper
• STRUKTURA, DZIA£ANIE I ROLA RECEPTORA- GAMMA PEROKSYSOMÓW AKTYWOWANEGO

  year unknowncites this paper